Marc Sze

As a Principal Scientist at Merck, Marc Sze leads a dynamic computational biology team dedicated to pioneering advancements in early discovery immunology. With a robust focus on analytical challenges, Marc's team is at the forefront of elucidating the complex biology underlying critical therapeutic targets. Their work encompasses a broad spectrum of inquiries, including mechanisms of action (MoA), target engagement, and biomarker development, all of which are essential for driving innovative treatments in immunology.

Marc's expertise lies in the sophisticated analysis of diverse genomics and proteomics data. His team employs cutting-edge techniques such as bulk RNA sequencing, low-input RNA sequencing, single-cell RNA sequencing, and whole-exome sequencing, alongside advanced proteomics methodologies like OLINK and mass spectrometry. This comprehensive approach enables the team to generate actionable insights that inform traditional target teams and facilitate early target identification.

In addition to his technical acumen in data strategies and biostatistics, Marc is adept at integrating systems biology principles to create holistic models that reflect the intricate interplay of biological systems. His proficiency in computational biology and bioinformatics, coupled with programming skills in Python, empowers his team to tackle complex datasets and derive meaningful conclusions that propel research forward. Under Marc's leadership, the team not only contributes to Merck's mission of advancing healthcare but also fosters a collaborative environment that encourages innovative thinking and scientific rigor. Through their work, they are poised to make significant contributions to the understanding and treatment of immunological diseases, ultimately improving patient outcomes.